StockMarketWire.com - Imperial Innovations Group has led a £22m funding round for PsiOxus Therapeutics, alongside Invesco Perpetual, and together with new investors SR One and Lundbeckfond Ventures.
PsiOxus Therapeutics, based in Oxfordshire, is a development stage biotechnology company using non-traditional approaches to novel therapeutics for cancer, wasting diseases and other unmet clinical needs.
PsiOxus will use the funds to advance the clinical development of ColoAd1, a highly potent broad-spectrum anti-cancer therapeutic capable of destroying tumour cells at minute concentrations.
A series of phase I and phase II clinical trials for the treatment of colorectal cancer and other forms of solid cancer will be initiated.
At 8:46am: [LON:IVO] Ivory & Sime Optimum share price was +14p at 300.5p
Story provided by StockMarketWire.com
MoneyAM.com
MoneyAM website is aimed at investors of all levels of experience including City professionals, investors and full-time traders.
- Free live share prices
- Free live watch lists
- UK and Worldwide Indices
- Live market News
- Company Fundamentals
- Charts - Intraday and historic
- Stock Portfolio
Shares Magazine
Shares is the leading weekly publication for high net worth private investors and stock market professionals and as such is read weekly by thousands of private investors, analysts, fund managers, stockbrokers and company directors.
Broker Forecasts
Brokerforecasts.com publishes equity upgrades, downgrades, reiterations, resumption and drops in coverage, as well as price target changes to a desktop or via alerts to email.
All recommendations are delivered and updated as soon as possible after release. The majority will be on brokerforecasts.com prior to market open.
Directors Holdings
Company directors know the state of their business better than anyone. That's why professional investors like to keep a close watch on the directors who are buying and selling and often follow their lead. DirectorsHoldings.com provides all the necessary screening and search tools.